WeVote
Log In

Bill

Bill

S 1263

Operational Security Act of 2025

119th Congress Introduced by Andy Kim and 2 co-sponsors

Bill S 1263 prohibits selling hazardous inhalants to those under 21, aiming to protect youth from substance abuse and its health risks while ensuring retailer compliance.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 1263

Summary of Bill S 1263

Title

Prohibits the sale of certain hazardous inhalants to persons under the age of twenty-one

Bill Information

  • Bill Number: S 1263
  • Status: Referred to Health
  • Introduced: January 08, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 1263 is to enhance public health and safety by prohibiting the sale of specific hazardous inhalants to individuals under the age of twenty-one. This legislation aims to reduce the risk of substance abuse and associated health issues among young people, particularly those who may be vulnerable to the dangers of inhalant use.

Key Provisions

  • Age Restriction: The bill establishes a legal age limit of twenty-one years for the purchase of designated hazardous inhalants.
  • Definition of Hazardous Inhalants: While the bill does not specify which inhalants are included, it is expected that the legislation will define these substances in detail, likely focusing on those known to pose significant health risks when misused.
  • Enforcement Measures: The bill may include provisions for enforcement, such as penalties for retailers who violate the age restriction, although specific enforcement mechanisms are not detailed in the current version.

Impact

  • Target Population: The bill primarily affects individuals under the age of twenty-one, aiming to protect this demographic from the potential harms associated with inhalant abuse.
  • Retailers: Businesses that sell inhalants will need to comply with the new regulations, which may involve training staff to verify the age of customers and implementing systems to prevent sales to minors.
  • Public Health: By restricting access to hazardous inhalants, the bill seeks to mitigate health risks, including addiction and other adverse health effects associated with inhalant use.

Procedural Aspects

  • Legislative Action: As of January 8, 2025, the bill has been referred to the Health Committee for further consideration. The timeline for additional hearings or votes has not yet been established.
  • Related Legislation: This bill is related to prior-session Bill S 8156 and has a companion bill, A 5192, which may provide additional context or support for its provisions.

Conclusion

Bill S 1263 represents a proactive approach to safeguarding young individuals from the dangers of hazardous inhalants. By instituting an age restriction on sales, the legislation aims to promote healthier choices and reduce the prevalence of inhalant abuse among minors. Further developments will be monitored as the bill progresses through the legislative process.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.